|
_______________________________________________________________
Reglan Tardive Dyskinesia Neurological Disorder Lawsuits
(GERD and GER Drug
Reaction Lawyer)
Tardive
dyskinesia is a neurological disorder that exhibits itself
through repetitive, involuntary, & purposeless movements
like grimacing; tongue protrusion; lip smacking, puckering &
pursing; and rapid eye blinking. Victims of tardive
dyskinesia also can exhibit rapid & involuntary movements of
the arms and legs. The neurological disorder can be caused by
Reglan Tablets, Reglan Oral Disintegrating Tablets,
Metoclopramide Oral Solution, and Reglan Injections.
If your
child, yourself, or
someone else that you love has been given Reglan and has exhibited Tardive
Dyskinesia symptoms, make sure that you get this person to a
proper medical doctor, then feel free to
submit an
inquiry or
send an e-mail to
Reglan Tardive Dyskinesia lawyer Jason Coomer.
FDA Requires Boxed Warning for Reglan and other
Metoclopramide Containing Drugs (Tardive Dyskinesia
GER and GERD Lawsuits)
On February 26, 2009,
the U.S. Food and Drug Administration announced that
manufacturers of metoclopramide, a drug used to treat
gastrointestinal disorders, must add a boxed warning to
their drug labels about the risk of its long-term or
high-dose use. Chronic use of metoclopramide has been linked
to tardive dyskinesia, which may include involuntary and
repetitive movements of the body, even after the drugs are
no longer taken.
Manufacturers are required to implement a
risk evaluation and mitigation strategy, or REMS, to ensure
patients are provided with a medication guide that discusses
this risk.
The FDA wants patients and health care
professionals to know about this risk so they can make
informed decisions about treatment, said Janet Woodcock,
M.D., director of the FDA's Center for Drug Evaluation and
Research. The chronic use of metoclopramide therapy should
be avoided in all but rare cases where the benefit is
believed to outweigh the risk.
Current product labeling warns of the
risk of tardive dyskinesia with chronic metoclopramide
treatment. The development of this condition is directly
related to the length of time a patient is taking
metoclopramide and the number of doses taken. Those at
greatest risk include the elderly, especially older women,
and people who have been on the drug for a long time.
Tardive dyskinesia is characterized by
involuntary, repetitive movements of the extremities, or lip
smacking, grimacing, tongue protrusion, rapid eye movements
or blinking, puckering and pursing of the lips, or impaired
movement of the fingers. These symptoms are rarely
reversible and there is no known treatment. However, in some
patients, symptoms may lessen or resolve after
metoclopramide treatment is stopped.
Metoclopramide works by speeding up the
movement of the stomach muscles, thus increasing the rate at
which the stomach empties into the intestines. It is used as
a short-term treatment of gastroesophageal reflux disease in
patients who have not responded to other therapies, and to
treat diabetic gastroparesis (slowed emptying of the
stomach's contents into the intestines). It is recommended
that treatment not exceed three months.
Metoclopramide is available in a variety
of formulations including tablets, syrups and injections.
Names of metoclopramide-containing products include Reglan
Tablets, Reglan Oral Disintegrating Tablets, Metoclopramide
Oral Solution, and Reglan Injection. More than two million
Americans use these products.
Recently published analyses suggest that
metoclopramide is the most common cause of drug-induced
movement disorders. Another analysis of study data by the
FDA showed that about 20 percent of patients in that study
who used metoclopramide took it for longer than three
months. The FDA has also become aware of continued
spontaneous reports of tardive dyskinesia in patients who
used metoclopramide, the majority of whom had taken the drug
for more than three months.
Reglan Tardive Dyskinesia Lawsuits (GER and GERD
Malpractice)
Gastroesophageal reflux disease (GERD) is
a more serious form of gastroesophageal reflux (GER), which
is common. GER occurs when the lower esophageal
sphincter (LES) opens spontaneously, for varying periods of
time, or does not close properly and stomach contents rise
up into the esophagus. GER is also called acid reflux or
acid regurgitation, because digestive juices—called
acids—rise up with the food.
When acid reflux occurs, food or fluid
can be tasted in the back of the mouth. When refluxed
stomach acid touches the lining of the esophagus it may
cause a burning sensation in the chest or throat called
heartburn or acid indigestion. Occasional GER is common and
does not necessarily mean one has GERD. Persistent reflux
that occurs more than twice a week is considered GERD, and
it can eventually lead to more serious health problems.
People of all ages can have GERD.
An estimated two-thirds of all infants
suffer from GER, though the pathological condition called
GERD (gastroesophageal reflux disease) affects approximately
only one in 300 babies.
Reglan is a neuroleptic medication used
to treat gastrointestinal problems that have had many cases
of Tardive Dyskinesia reported in response to it. Reglan is
supposed to increase the stomach and small intestine
contractions to help the passage of food. As every
medication, Reglan has side effects associated to it and
some of them are very serious. In February 1996, the FDA
warned that Reglan causes an increased risk of Parkinsonism.
Reglan is a dopamine antagonist that
increases lower esophageal sphincter pressure and improves
gastrointestinal emptying. The FDA approved Reglan, which is
manufactured by Baxter Healthcare Corporation, for
short-term treatment (between 4 and 12 weeks) of these
conditions only after conservative methods of treatment have
failed. However, it is common that patients are prescribed
Reglan for longer than 12 weeks, which is against FDA
recommendations.
This is problematic because prolonged use
of Reglan can cause Tardive Dyskinesia, a serious and often
irreversible movement disorder. Infants who are given Reglan
appear to be at an even greater risk for this serious drug
side effect.
The symptoms a person can experience from
Tardive Dyskinesia can vary from mild barely noticeable
facial ticks and involuntary movements to severe problems.
Severe cases of Tardive Dyskinesia can have a significant
impact on a person's life disabling them from normal
functioning. Severe facial ticks and involuntary body
movements can be extremely embarrassing cause a person to
withdraw from social interactions.
Texas Tardive Dyskinesia Lawyer (Drug
Reactions)
He works with other Reglan Tarive Dyskinesia Lawyers including Houston
Tardive Dyskinesia lawyers, Dallas GERD Medical Malpractice
Lawyers, San Antonio GERD Malpractice Lawyers, and
other Austin Reglan Medical Negligence Lawyers on a variety of
product liability and
medical malpractice lawsuits.
If you, your child, or someone you love is suffering
from tardive dyskinesia, Austin Texas Reglan Tardive Dyskinesia lawyer, Jason S. Coomer, helps
individuals that have been injured from treatments for GERD
or GER as well as high doses or
long
term use of other neuroleptic medications.
If you have a question about a anti-psychotic medication or
other neurological or gastrointestinal medications that may
have caused Tardive Dyskinesia,
contact Texas
Reglan Tardive Dyskinesia Lawyer Jason Coomer.
|
